Are you Dr. Kim?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 23 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1301 N Rose Dr
Placentia, CA 92870Phone+1 714-993-2000- Is this information wrong?
Summary
- Dr. Youn Kim, MD is a board certified anesthesiologist in Placentia, California. He is currently licensed to practice medicine in California, Pennsylvania, and Massachusetts. He is affiliated with Placentia-Linda Hospital.
Education & Training
- New York Medical College at Metropolitan HospitalResidency, Anesthesiology, 1982 - 1984
- Montefiore - Mount Vernon HospitalInternship, Transitional Year, 1981 - 1982
- Korea University College of MedicineClass of 1976
Certifications & Licensure
- CA State Medical License 1989 - 2021
- MA State Medical License 1982 - 1999
- PA State Medical License 1984 - 1990
- American Board of Anesthesiology Anesthesiology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
Clinical Trials
- Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma Start of enrollment: 2001 Apr 01
- Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma Start of enrollment: 2007 Jan 01
- Forodesine in the Treatment of Cutaneous T-Cell Lymphoma Start of enrollment: 2007 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 12 citationsMeasurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.Stacey McCaffrey, Ryan A. Black, Mitchell Nagao, Marjan Sepassi, Gaurav Sharma, Susan Thornton, Youn H. Kim, Julia Braverman> ;Journal of Medical Internet Research. 2019 Jan 7
- 7 citationsUtility of CD30, Ki-67, and p53 in assisting with the diagnosis of mycosis fungoides with large cell transformation.Shyam S. Raghavan, E. Hong, Youn H. Kim, Jinah Kim> ;Journal of Cutaneous Pathology. 2019 Jan 1
- Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.Kim, Y. H.,Bagot, M.,Pinter-Brown, L.,Rook, A. H.,Porcu, P.,Horwitz, S. M.,Whittaker, S.,Tokura, Y.,Vermeer, M.,Zinzani, P. L.,Sokol, L.,Morris, S.,Kim, E. J.,Ortiz-Ro...> ;Lancet Oncol.. 2018 Aug 14
- Join now to see all
Hospital Affiliations
- Stanford Health CarePalo Alto, California
- Placentia-Linda HospitalPlacentia, California